HPV-related cancer can affect men too, say doctors

Human Papillomavirus (HPV)-related disease, particularly cervical cancer, is the second highest cause of cancer among women in India.
Cervical cancer is preventable with timely vaccination and screening. Unfortunately, due to the lack of awareness, high vaccine cost and limited access, vaccination in India is very low at 1%, said doctors at the 'Conquer HPV and Cancer Conclave 2025' organised by Serum Institute of India, here, on Friday.
HPV vaccination is equally important for men too, as they can turn out to be silent carriers and transmit the disease to their sexual partner in later life, said the doctors.
Dr. I. Vani, Superintendent, King George Hospital (KGH); Dr. R. Vidya Rama, Professor of Obstetrics and Gynaecology, Andhra Medical College (AMC); Dr. Sunanda Rani Gutta, Director and Chief Consultant Gyneacologist of Nikitha Hospital; Dr. Sai Sunil Kishore Manem, Chief Neonatologist, Medicover Hospital; Dr. Buddha Murali Santosh, Neonatologist and Paediatrician, Motherly Women and Children Hospital, Vizag, were among those who participated in the programme.
Dr. Vidya Rama and Dr. Sunanda Rani explained that the age group of 9 to 15 was the best time for the administration of HPV vaccine for both girls and boys. Though the earlier vaccine (imported) was available for over 15 years in India, the poor compliance could be attributed to the lack of awareness, high cost and other factors.
'Indigenous vaccine'
Now, an indigenous vaccine (cervavac), brought out by Serum Institute of India, was available at a lower cost.
While HPV is commonly associated with cervical cancer in women, it also causes serious diseases in men, including penile cancer, oropharyngeal cancer and genital warts.
Unlike girls, for whom routine screening tests are available to detect early signs of HPV-related diseases, no such screening is available for men, hence prevention is crucial here, the doctors said.
Dr. Sunanda Rani said that another advantage of vaccination was that herd immunity would develop when the maximum number of people were administered with the vaccine.
She reminded of the slogan: 'Do teeke zindagi ki' (two vaccine doses for life) to create awareness on the need to take two doses of the vaccine for those in the target group.
'Highly effective'
Dr. Vani said that the HPV vaccine was effective up to 98%. She hoped that with the indigenous vaccine and low cost, the vaccination rate would increase to at least 90%. She said that FOGSI (Federation of Obstetrics and Gynaecological Societies of India) has appealed to the Government of India to make HPV vaccination a part of the universal immunisation programme and the government was said to be considering it.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

The Hindu

2 days ago

• The Hindu

T.N. government initiates steps to roll out HPV vaccination for girls aged 14

: Moving ahead to implement its budget announcement, Tamil Nadu has initiated the process to procure Human Papillomavirus (HPV) vaccines for girls aged 14. This is to prevent cervical cancer, which is the second most common cancer in women. The Tamil Nadu Medical Services Corporation (TNMSC) has floated tenders for the procurement, and the supply is most likely to reach hospitals in another three months. One of the key budget announcements for 2025-2026, the State government plans to progressively provide HPV vaccination to all girls aged 14 years. It allocated ₹36 crore for the purpose. In line with this announcement, the Health Department constituted a State Advisory Committee in April for the rollout of the HPV vaccination programme. The committee, which has the Health Secretary as its chairperson, comprises officials and experts. The directors of School Education, Public Health and Preventive Medicine, Medical and Rural Health Services, Medical Education and Research, Institute of Child Health, and Institute of Obstetrics and Gynaecology are among its members. Experts, including those in the field of HPV vaccination projects, and representatives from technical/partner agencies are also a part of the committee. 'The State Advisory Committee has discussed all modalities, including protocols for vaccination. Based on its recommendations, we have gone ahead with the procurement of vaccines. The TNMSC has floated the tenders to procure them,' T.S. Selvavinayagam, Director of Public Health and Preventive Medicine, said. He added that the programme would be initiated by vaccinating girl aged 14 (students of Class IX) in government and government-aided schools. 'Prior to vaccination, we will start creating awareness among children and their family members,' he said. Another official said it would take another three months for the supply to reach hospitals. Cancer Institute (WIA), in a year of launching its HPV vaccination initiative at its screening centre at Villupuram Government Hospital and Chennai, has so far administered around 3,500 doses of HPV vaccine, according to Jayashree Natarajan, Gynaecologic Oncologist and Associate Professor, Cancer Institute (WIA). 'The numbers are more in Chennai owing to high awareness levels,' she said. Cervical cancer is the second most common among women after breast cancer. However, it is still the most prevalent cancer in some rural areas, she said, adding: 'Vaccination is not going to prevent cervical cancer alone. It will prevent pre-invasive lesions that progress to cancer.' There are no concerns regarding the safety of the vaccines, she says. 'HPV vaccination programmes have been implemented in places such as Canada, Australia, New Zealand, and the United States. These countries have brought down the cervical cancer rates through screening and vaccination,' Dr. Jayashree said.

Hindustan Times

5 days ago

• Hindustan Times

Ludhiana district logs 8 new Covid cases

Ludhiana reported eight fresh COVID-19 cases on Tuesday, bringing the total number of active cases in the district to 29. The new cases include six men aged between 23 and 82, and two women aged 25 and 52. Out of these, six are from urban areas while two belong to rural parts of the district. The total reported cases so far stand at 55, with 24 patients having successfully completed home quarantine. Two COVID-related deaths have also been recorded. According to Dr Sheetal Narang, epidemiologist at the civil hospital, four of the eight patients were asymptomatic, and only one of them reported a mild sore throat. She further added that except for one patient, all others were vaccinated, and one had even received a booster dose. 'Currently, only three patients are hospitalised, showing symptoms such as fever, cough, and cold,' she said. Health officials are urging the public to remain vigilant and follow safety protocols, especially as some new cases involve people with no symptoms at all. They advised citizens to wear masks in crowded or poorly ventilated areas and to isolate themselves and consult a nearby health centre if they experience any symptoms like fever, cough, or difficulty in breathing. People are also advised to maintain proper hand hygiene, avoid unnecessary gatherings, and ensure good ventilation in indoor spaces.

Time of India

5 days ago

• Time of India

153% Jump in COVID Searches Reveals India's Vigilance Amid New Wave Fears

New Delhi: As India witnesses a resurgence of COVID-19 cases—with active infections surpassing the 7,000 mark—new search data from local search engine Justdial, reveals a significant shift in public behaviour. COVID-related searches spiked by 153 per cent nationwide between April and May 2025, reflecting a palpable increase in public concern and preparedness across cities. Among the top trends were an 8x increase in searches for government testing centres, a 77 per cent rise in insurance-related queries, and a threefold jump in vaccine centre lookups under the Pradhan Mantri Jan Arogya Yojana (PM-JAY). The capital city Delhi has emerged as the most proactive, with a 140 per cent rise in overall COVID-related searches and a 15x surge in government testing centre queries. According to Justdial's report, the renewed public interest spans both metros and smaller cities, indicating broader health awareness. In Mumbai, searches for private testing rose alongside a 26 per cent increase in insurance-related lookups. Kerala, meanwhile, recorded an 84 per cent surge in insurance searches, the highest in the country. ETHealthworld's Rashmi Kaur spoke to experts from healthcare facilities to understand on how they view the public's proactive approach. 'Yes, we are witnessing huge spikes in footfalls for COVID testing, especially for travelers and those with mild symptoms,' confirmed Dr. Diksha Goyal, Senior Consultant – Internal Medicine at Marengo Asia Hospitals, Gurugram. 'We've streamlined testing logistics, stocked up on kits and PPE, and trained our staff to handle the surge efficiently. Online bookings and electronic reporting are helping us reduce crowding and waiting times.' Dr. Deepak Sanghavi, Vice President of Operations at Agilus Diagnostics, emphasized that the rising interest in testing is not just reactive but also preventive. 'While there's no panic, people are clearly more alert. We're seeing increased demand from symptomatic individuals, their contacts, and even post-infection follow-ups—many opting for home sample collection,' he said. While numbers are rising, doctors believe the clinical picture is changing. 'Many cases are now presenting with milder, influenza-like symptoms such as nasal congestion, sore throat, and fatigue,' said Dr. Goyal. 'Severe respiratory distress is rare, particularly in vaccinated individuals. However, early detection remains tricky, as the symptoms are more insidious. High-risk groups still need close monitoring and timely care.' Dr. Sanghavi echoed, 'This is not the same panic-driven atmosphere we saw during earlier waves. Public behaviour now shows a desire for early awareness and informed action. That's a good sign.' Demand for Booster shots With immunity waning and infection trends climbing, public interest in booster doses is seeing a revival. 'There's a clear uptick in people—especially seniors—seeking booster shots. While national advisories are awaited, state-level initiatives are encouraging precautionary vaccination for high-risk groups,' said Dr. Goyal. What sets this surge apart from earlier waves is the public's proactive response—seeking out information, verifying coverage options, and opting for safe testing methods like home collection. 'Healthcare providers and diagnostics labs are more prepared than ever before,' said Dr. Sanghavi. 'India's healthcare infrastructure, bolstered by earlier experiences, is well-equipped to manage this rise efficiently.' While health authorities monitor the evolving situation, experts agree that public vigilance, timely testing, accurate information, and vaccinations remain the most effective tools in preventing another full-blown crisis.